Tetraphase Pharmaceuticals, Inc. (TTPH): Price and Financial Metrics
Tetraphase Pharmaceuticals, Inc. (TTPH)
Today's Latest Price: $2.20 USD
Updated Jul 28 7:55pm
Add TTPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
TTPH Stock Summary
- With a year-over-year growth in debt of -92.22%, Tetraphase Pharmaceuticals Inc's debt growth rate surpasses merely 1.81% of about US stocks.
- Revenue growth over the past 12 months for Tetraphase Pharmaceuticals Inc comes in at -57.03%, a number that bests only 2.98% of the US stocks we're tracking.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for TTPH comes in at 146.09% -- higher than that of 97.54% of stocks in our set.
- Stocks that are quantitatively similar to TTPH, based on their financial statements, market capitalization, and price volatility, are BIOC, APDN, DDD, MBII, and SCWX.
- Visit TTPH's SEC page to see the company's official filings. To visit the company's web site, go to www.tphase.com.
TTPH Stock Price Chart Technical Analysis Charts
TTPH Price/Volume Stats
| Current price | $2.20 | 52-week high | $8.60 |
| Prev. close | $2.28 | 52-week low | $0.56 |
| Day low | $2.18 | Volume | 282,600 |
| Day high | $2.27 | Avg. volume | 932,542 |
| 50-day MA | $2.42 | Dividend yield | N/A |
| 200-day MA | $2.32 | Market Cap | 15.98M |
Tetraphase Pharmaceuticals, Inc. (TTPH) Company Bio
Tetraphase Pharmaceuticals is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create antibiotics for serious and life-threatening MDR bacterial infections. The company was founded in 2006 and is based in Watertown, Massachusetts.
Loading social stream, please wait...